AU4451797A - 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds - Google Patents

3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds

Info

Publication number
AU4451797A
AU4451797A AU44517/97A AU4451797A AU4451797A AU 4451797 A AU4451797 A AU 4451797A AU 44517/97 A AU44517/97 A AU 44517/97A AU 4451797 A AU4451797 A AU 4451797A AU 4451797 A AU4451797 A AU 4451797A
Authority
AU
Australia
Prior art keywords
alkoxyisoxazol
substituted
carboxylic acid
acid compounds
amino carboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU44517/97A
Other versions
AU733004B2 (en
Inventor
Benny Bang-Andersen
Klaus Peter Bogeso
Povl Krogsgaard-Larsen
Sibylle Moltzen Lenz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of AU4451797A publication Critical patent/AU4451797A/en
Application granted granted Critical
Publication of AU733004B2 publication Critical patent/AU733004B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU44517/97A 1996-10-04 1997-10-03 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds Ceased AU733004B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK1092/96 1996-10-04
DK109296 1996-10-04
PCT/DK1997/000426 WO1998015542A1 (en) 1996-10-04 1997-10-03 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds

Publications (2)

Publication Number Publication Date
AU4451797A true AU4451797A (en) 1998-05-05
AU733004B2 AU733004B2 (en) 2001-05-03

Family

ID=8100908

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44517/97A Ceased AU733004B2 (en) 1996-10-04 1997-10-03 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds

Country Status (26)

Country Link
US (1) US6200999B1 (en)
EP (1) EP0934286B1 (en)
JP (1) JP2001501630A (en)
KR (1) KR20000048908A (en)
CN (1) CN1238766A (en)
AR (1) AR008880A1 (en)
AT (1) ATE230734T1 (en)
AU (1) AU733004B2 (en)
BG (1) BG103348A (en)
BR (1) BR9712198A (en)
CA (1) CA2268028C (en)
CZ (1) CZ116899A3 (en)
DE (1) DE69718338T2 (en)
EA (1) EA001625B1 (en)
ES (1) ES2189978T3 (en)
HU (1) HUP0000084A3 (en)
IL (1) IL129135A0 (en)
IS (1) IS5009A (en)
NO (1) NO312961B1 (en)
NZ (1) NZ334798A (en)
PL (1) PL332553A1 (en)
SK (1) SK42899A3 (en)
TR (1) TR199900724T2 (en)
UA (1) UA52698C2 (en)
WO (1) WO1998015542A1 (en)
ZA (1) ZA978877B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73749C2 (en) * 1999-11-01 2005-09-15 Diarylenines
ES2269458T3 (en) * 2000-09-15 2007-04-01 Vertex Pharmaceuticals Incorporated ISOXAZOLES AND ITS USE AS INHIBITORS OF THE ERK.
US20040106794A1 (en) * 2001-04-16 2004-06-03 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
UA78529C2 (en) * 2001-10-10 2007-04-10 Wyeth Corp Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain
US20040152694A1 (en) * 2003-02-04 2004-08-05 Istvan Kurucz Methods and compositions for treating inflammatory disorders of the airways
MXPA05010760A (en) 2003-04-09 2005-12-12 Wyeth Corp Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists.
TW200514775A (en) 2003-10-22 2005-05-01 Wyeth Corp Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
EP1937674A1 (en) * 2005-10-11 2008-07-02 F.Hoffmann-La Roche Ag Isoxazole derivatives
US8722714B2 (en) 2008-01-16 2014-05-13 The Honk Kong University of Science and Technology Oxazolidine derivatives as NMDA antagonists
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
TW201609719A (en) 2014-05-28 2016-03-16 美國禮來大藥廠 6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonists
US10442768B2 (en) 2016-01-21 2019-10-15 Agro-Kanesho Co., Ltd. Method for producing 2-aminonicotinic acid benzyl ester derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0456519T3 (en) 1990-05-11 1994-11-07 Sankyo Co Piperidyloxy and quinuclidinyloxyisoxazole derivatives, their preparation and their therapeutic use
ATE182139T1 (en) 1992-10-23 1999-07-15 Merck Sharp & Dohme DOPAMINE RECEPTOR SUBTYPE LIGANDS
DK124393D0 (en) * 1993-11-03 1993-11-03 Lundbeck & Co As H COMPOUNDS

Also Published As

Publication number Publication date
ATE230734T1 (en) 2003-01-15
JP2001501630A (en) 2001-02-06
KR20000048908A (en) 2000-07-25
TR199900724T2 (en) 1999-06-21
AU733004B2 (en) 2001-05-03
CZ116899A3 (en) 1999-09-15
NO991561D0 (en) 1999-03-30
HUP0000084A2 (en) 2000-06-28
WO1998015542A1 (en) 1998-04-16
BR9712198A (en) 1999-08-31
IS5009A (en) 1999-03-23
EA199900358A1 (en) 1999-10-28
PL332553A1 (en) 1999-09-13
CN1238766A (en) 1999-12-15
CA2268028C (en) 2003-03-18
NO312961B1 (en) 2002-07-22
ZA978877B (en) 1998-04-17
SK42899A3 (en) 1999-08-06
US6200999B1 (en) 2001-03-13
EA001625B1 (en) 2001-06-25
NZ334798A (en) 2000-06-23
DE69718338D1 (en) 2003-02-13
BG103348A (en) 1999-11-30
NO991561L (en) 1999-06-04
AR008880A1 (en) 2000-02-23
EP0934286A1 (en) 1999-08-11
EP0934286B1 (en) 2003-01-08
UA52698C2 (en) 2003-01-15
IL129135A0 (en) 2000-02-17
DE69718338T2 (en) 2003-10-16
CA2268028A1 (en) 1998-04-16
HUP0000084A3 (en) 2001-12-28
ES2189978T3 (en) 2003-07-16

Similar Documents

Publication Publication Date Title
AU4893993A (en) Carboxylic acid derivatives
AU5703398A (en) Novel compounds
AU6482398A (en) Sulfonylaminocarboxylic acids
AU5230693A (en) Carboxylic acid derivatives
AU2602297A (en) Thickened acid composition
AU1942397A (en) Fused-ring carboxylic acid derivatives
HU9401917D0 (en) Propionic acid derivatives
AU1559199A (en) Isothiazolcarboxylic acid derivatives
AU4451797A (en) 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
AU1364995A (en) 5-vinyl- and 5-ethinyl-quinolone- carboxylic acids
AU7940598A (en) Quinolone carboxylic acid derivatives
AU3093697A (en) Aminophthalic acid derivatives
AU697025B2 (en) Quinoline carboxylic acid
AU3443897A (en) Glyoxylic acid derivatives
AU6926294A (en) Carboxylic acid amide benzothiophene-s-oxides
AU5345798A (en) Fructan-polycarboxylic acid
AU5423298A (en) Novel compounds
HU9601167D0 (en) 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
AU4311096A (en) Clavulanic acid salts
IL123213A0 (en) Carboxylic acid derivatives
AU2629295A (en) Trifluoromethylquinolinecarboxylic acid derivative
AU3711697A (en) Novel compounds
AU5319898A (en) Glyoxylic acid amides
SI0934286T1 (en) 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
AU8214498A (en) Glyoxylic acid amides

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired